Two Ebola drugs show 90% survival rate

Google+ Pinterest LinkedIn Tumblr

Scientists have made immense progress in finding a cure for the Ebola Virus, and it may soon become a preventable and treatable disease.

After several trials, two drugs have shown significant improvement with their survival rates.

Four have been tried on several patients in the Democratic Republic of Congo where there is a major outbreak of the virus, but only two of the drugs have shown great success.

It has been shown that if treated early, with the most effective drugs, more than 90% of infected people will survive.

The drugs will henceforth be used to treat all patient in DR Congo.

The drugs named REGN-EB3 and mAb114 works by attacking the Ebola Virus with antibodies, neutralizing its impact on human cells.

According to Director of NIAID, Dr Anthony Fauci, these two drugs are the first drugs that have clearly shown in a sound study a significant decrease in deaths.

These drugs were developed using antibodies harvested from survivors of Ebola, a disease which has killed over 1,800 people in DR Congo in the past years.

Two other treatments, called ZMapp and Remdesivir has been dropped from trials as they are found to be less effective for this fast killing Virus.

It has been confirmed that more than 90% of people will survive if they are treated early as the survival rate among patients with low levels of the virus in their blood as high as 94% when they take REGN-EB3 and 89% when given mAb114.

Write A Comment